Equity ETFs Biotech ETFs Pop as Bristol-Myers Squibb Set to Acquire Celgene By Max ChenJanuary 3, 2019
Equity ETFs Facebook CEO Mark Zuckerberg Dials Up Aggression as Shares, Tech ETFs Falter By Ben HernandezNovember 19, 2018
Leveraged & Inverse Channel Biotech ETFs Hoping This Post-Election Trend Doesn’t Repeat By Brenton GarenNovember 8, 2018
Alternative ETFs China Tech ETFs that Could Benefit from Google-JD.com Partnership By Ben HernandezJune 18, 2018
